An Open-label Trial to Determine Increased Red Blood Cell Production in Subjects With Anemia of Chronic Disease
| Status: | Completed |
|---|---|
| Conditions: | Anemia |
| Therapuetic Areas: | Hematology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/2/2016 |
| Start Date: | June 2013 |
| End Date: | September 2013 |
| Contact: | Stephanie Pavlik, CRA |
| Email: | spavlik@ptlcentral.com |
| Phone: | 310-474-9809 |
An Open-label Trial of an Erythropoietin Stimulating System to Determine Increased Red Blood Cell Production in Subjects Diagnosed With Anemia of Chronic Disease
The objective of this study is to measure the change in blood values after the
administration of an amino acid based erythropoietin stimulating system.
administration of an amino acid based erythropoietin stimulating system.
Inclusion Criteria:
1. M/F patients 18 years old and over, non-pregnant/lactating
2. Hemoglobin < 10 female,<11 male
3. Ferritin > upper limit of normal for lab indicative of chronic anemia
4. Anemia of chronic disease
5. Crt. < 3.0
Exclusion Criteria:
1. Currently taking other amino acid formulations.
2. Pregnant or unwilling to use adequate birth control for the duration of the study.
3. Excessive alcohol or illicit drug use.
4. Unwilling or unable to sign informed consent.
5. Myocardial infarction within the last 6 months.
6. Patients ever having taken or currently taking an erythropoietin medication.
7. Iron deficiency (add criteria).
8. On dialysis.
9. Malignancy other than non-melanoma skin cancer within the last 5 years. If has such
malignancy, must have documentation of no recurrence for at least 5 years.
10. Liver cirrhosis (add criteria).
We found this trial at
1
site
Click here to add this to my saved trials
